Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable (BEP) Slides After $650M Equity Raise: Proceeds Target Isagen Stake & Baseload Growth (11/11/2025)

Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: BEP.UN) traded lower today after unveiling a fresh equity financing package tied to its push into “firm” clean power—including hydro and nuclear—and the recently completed increase in its stake in Colombia’s Isagen. Here’s
11 November 2025
LivePerson (LPSN) Soars After Citron Shout‑Out: Q3 Beat, Guidance Lift, and AI ‘Conversation Simulator’ Fuel Rally — 11/11/2025

LivePerson (LPSN) Soars After Citron Shout‑Out: Q3 Beat, Guidance Lift, and AI ‘Conversation Simulator’ Fuel Rally — 11/11/2025

LivePerson, Inc. (NASDAQ: LPSN) jumped sharply on Tuesday after a bullish note from Citron Research added fuel to momentum from the company’s third‑quarter results released late Monday. As of mid‑afternoon, shares traded near $6.25 and touched an intraday high of
The RealReal (REAL) spikes to new highs after Q3 beat; Wall Street lifts targets to $15–$16 — all the news investors need today (Nov. 11, 2025)

The RealReal (REAL) spikes to new highs after Q3 beat; Wall Street lifts targets to $15–$16 — all the news investors need today (Nov. 11, 2025)

The luxury resale leader topped Q3 estimates Monday and raised guidance. By Tuesday, shares hit fresh 52‑week highs as BTIG, UBS, Northland, KeyBanc and Baird updated calls. The RealReal, Inc. (NASDAQ: REAL) extended Monday evening’s earnings momentum into Tuesday’s session,
Grab (GRAB) News Today — Nov 11, 2025: SoftBank fuels GoTo shake‑up, Grab launches lane‑level GPS pilot, AGM date set; GoTo says no deal yet

Grab (GRAB) News Today — Nov 11, 2025: SoftBank fuels GoTo shake‑up, Grab launches lane‑level GPS pilot, AGM date set; GoTo says no deal yet

Merger chatter intensifies—but no agreement as of today A Bloomberg report today says a group of GoTo backers—including SoftBank—is pushing to replace CEO Patrick Walujo, a shake‑up that investors view as potentially smoothing the way for renewed Grab–GoTo deal discussions.
Tesla (TSLA) Today — Nov. 11, 2025: China Sales Sink to 3‑Year Low, Model Y & Cybertruck Chiefs Exit, as Musk’s AI Pivot Takes Center Stage

Tesla (TSLA) Today — Nov. 11, 2025: China Sales Sink to 3‑Year Low, Model Y & Cybertruck Chiefs Exit, as Musk’s AI Pivot Takes Center Stage

On Nov. 11, 2025, Tesla’s China sales hit a three‑year low, two vehicle‑program leaders departed, shareholders’ $1T Musk award reverberated, and fresh commentary put Optimus and FSD ambitions back in the spotlight. TSLA slips intraday. TSLA stock snapshot (intraday) As
CleanSpark (CLSK) Upsizes $1.15B Zero‑Coupon Convertible; Shares Dip as Funds Target Power, AI Data Centers & $460M Buyback (Nov. 11, 2025)

CleanSpark (CLSK) Upsizes $1.15B Zero‑Coupon Convertible; Shares Dip as Funds Target Power, AI Data Centers & $460M Buyback (Nov. 11, 2025)

What happened today CleanSpark, Inc. (Nasdaq: CLSK) upsized and priced a private offering of $1.15 billion in 0% convertible senior notes due 2032. The terms set an initial conversion rate of 52.1832 shares per $1,000 of notes, equating to an
Hesai Group (HSAI) Turns Profitable in Q3, Wins Exclusive Li Auto Lidar Deal, and Guides Stronger Q4 — Nov. 11, 2025

Hesai Group (HSAI) Turns Profitable in Q3, Wins Exclusive Li Auto Lidar Deal, and Guides Stronger Q4 — Nov. 11, 2025

Hesai Group (NASDAQ: HSAI; HKEX: 2525) delivered two headlines today: a return to profitability on record quarterly results and a fresh commercial win as the exclusive lidar supplier for Li Auto’s next‑generation assisted‑driving platform. Management also guided to double‑digit growth
Quoin Pharmaceuticals (QNRX) Soars After Hitting 4%/5% Topical Rapamycin Targets; Clinical Batches This Quarter, Human Trials 1H 2026 [Nov. 11, 2025]

Quoin Pharmaceuticals (QNRX) Soars After Hitting 4%/5% Topical Rapamycin Targets; Clinical Batches This Quarter, Human Trials 1H 2026 [Nov. 11, 2025]

What happened today Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) announced that it has successfully achieved target loading concentrations for two topical rapamycin delivery technologies—4% in its lotion and 5% in a dermal patch. The company said it will start manufacturing clinical
1 53 54 55 56 57 232
Go toTop